Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on July 10, 2024, detailing the expiration and results of a tender offer conducted by its wholly owned subsidiary, Orion Acquisition AB. The tender offer aimed to acquire all outstanding common shares and American Depositary Receipts (ADRs) of Olink Holding AB (publ). This event signifies a major step towards Thermo Fisher's potential acquisition of Olink, a development that could have significant strategic and financial implications for the company and its shareholders.
Key Highlights
- 1Thermo Fisher's subsidiary, Orion Acquisition AB, successfully completed its tender offer for Olink Holding AB.
- 2The tender offer sought to acquire all outstanding common shares and ADRs of Olink.
- 3The filing confirms the expiration and results of the tender offer.
- 4A press release dated July 10, 2024, contains the detailed results and is attached as an exhibit.
- 5This action is a critical step in Thermo Fisher's previously announced plan to acquire Olink.